lamivudine triphosphate

Known as: 3TC-TP 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2018
012319982018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Our previous negative ESI-LC-MS/MS method developed for nucleoside reverse transcriptase inhibitor (NRTI) triphosphate (-TP… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVE To evaluate the potential for a pharmacologic mechanism to explain suboptimal virologic responses observed in a triple… (More)
Is this relevant?
2004
2004
Once-daily administration of 300 mg of lamivudine in combination with other antiretroviral agents has been proposed as a possible… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVES Nucleoside analog reverse transcriptase inhibitors (NRTI) are used in virtually all anti-HIV regimens. Clinical… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2002
2002
In this paper, we describe the development and use of enzymatic assays to determine intracellular lamivudine triphosphate (3TCTP… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Success in treating hepatitis B virus (HBV) infection with nucleoside analog drugs like lamivudine is limited by the emergence of… (More)
Is this relevant?
2001
2001
When human immunodeficiency virus type 1 (HIV-1) is selected for resistance to 3TC, the methionine normally present at position… (More)
Is this relevant?
2000
2000
OBJECTIVE To quantitate intracellular concentrations of zidovudine and lamivudine triphosphate and explore relationships with… (More)
Is this relevant?
2000
2000
Highly active antiretroviral therapy (HAART) is the standard treatment for infection with human immunodeficiency virus (HIV). The… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
Highly Cited
1998
Highly Cited
1998
To determine whether adefovir is active against lamivudine-resistant hepatitis B virus (HBV), the inhibition constants of… (More)
Is this relevant?